Beyond comparing means: The usefulness of analyzing interindividual variation in gene expression for identifying genes associated with cancer development

Journal of Bioinformatics and Computational Biology

Volumn 10, Issue 2, 2012, Pages

  Gorlov, Ivan P ^a   Byun, Jinyoung ^a   Zhao, Hongya ^a,b   Logothetis, Christopher J ^a   Gorlova, Olga Y ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b SHENZHEN POLYTECHNIC   (China)

Author keywords

Gene expression; interindividual variation in gene expression; lung cancer; prostate cancer

Indexed keywords

TUMOR MARKER;

ARTICLE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; GENETICS; HUMAN; LUNG TUMOR; MALE; METABOLISM; NEOPLASM; PROSTATE TUMOR;

GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VARIATION; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASMS; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84859768428     PISSN: 02197200     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0219720012410132     Document Type: Article

References (24)

1. Pritchard CC, Nelson PS, Gene expression profiling in the developing prostate, Differentiation 76:624-640, 2008. (Pubitemid 352032740)
2. Sikaroodi M, Galachiantz Y, Baranova A, Tumor markers: The potential of "omics" approach, Curr Mol Med 10:249-357, 2011.
3. Tomlins SA, Rubin MA, Chinnaiyan AM, Integrative biology of prostate cancer progression, Annu Rev Pathol 1:243-271, 2006.
4. Hsiao YH, Chou MC, Fowler C, Mason JT, Man YG, Breast cancer heterogeneity: Mechanisms, proofs, and implications, J Cancer 1:6-13, 2010.
5. Heng HH, Bremer SW, Stevens JB, Ye KJ, Liu G, Ye CJ, Genetic and epigenetic heterogeneity in cancer: A genome-centric perspective, J Cell Physiol 220:538-547, 2009.
6. Berry D, Breast cancer heterogeneity may explain peaks in recurrence, Int J Surg 3:287, 2005. (Pubitemid 43129690)
7. Symmans WF, Liu J, Knowles DM, Inghirami G, Breast cancer heterogeneity: Evaluation of clonality in primary and metastatic lesions, Hum Pathol 26:210-216, 1995.
8. Hou J, Aerts J, den Hamer B, et al., Gene expression-based classification of non-small cell lung carcinomas and survival prediction, PLoS One 5:e10312, 2010.
9. Chandran UR, Ma C, Dhir R, et al., Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process, BMC Cancer 7:64, 2007.
10. Yue P, Melamud E, Moult J, SNPs3D: Candidate gene and SNP selection for association studies, BMC Bioinformatics 7:166, 2006.
11. Ashburner M, Ball CA, Blake JA, et al., Gene ontology: Tool for the unification of biology, The Gene Ontology Consortium, Nat Genet 25:25-29, 2000. (Pubitemid 30257031)
12. Dennis G Jr, Sherman BT, Hosack DA, et al., DAVID: Database for Annotation, Visualization, and Integrated Discovery, Genome Biol 4:P3, 2003.
13. Gorlov IP, Byun J, Gorlova OY, Aparicio AM, Efstathiou E, Logothetis CJ, Candidate pathways and genes for prostate cancer: A meta-analysis of gene expression data, BMC Med Genomics 2:48, 2009.
14. Gorlov IP, Sircar K, Zhao H, et al., Prioritizing genes associated with prostate cancer development, BMC Cancer 10:599, 2010.
15. Gorlov IP, Gallick GE, Gorlova OY, Amos C, Logothetis CJ, GWAS meets microarray: Are the results of genome-wide association studies and gene-expression profiling consistent? Prostate cancer as an example, PLoS One 4:e6511, 2009.
16. Molinié V, [Gleason's score: Update in 2008], Ann Pathol 28:350-353, 2008.
17. Blasberg JD, Goparaju CM, Pass HI, Donington JS, Lung cancer osteopontin isoforms exhibit angiogenic functional heterogeneity, J Thorac Cardiovasc Surg 139:1587-1593, 2010.
18. Nagai Y, Miyazawa H, Huqun, et al., Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp, Cancer Res 65:7276-7282, 2005. (Pubitemid 41161259)
19. Tsubokawa F, Nishisaka T, Takeshima Y, Inai K, Heterogeneity of expression of cytokeratin subtypes in squamous cell carcinoma of the lung: With special reference to CK14 overexpression in cancer of high-proliferative and lymphogenous metastatic potential, Pathol Int 52:286-293, 2002. (Pubitemid 34587814)
20. Krause FS, Feil G, Bichler KH, Schrott KM, Akcetin ZY, Engehausen DG, Heterogeneity in prostate cancer: Prostate specific antigen (PSA) and DNA cytophotometry, Anticancer Res 25:1783-1785, 2005. (Pubitemid 40896803)
21. Meghani SH, Lee CS, Hanlon AL, Bruner DW, Latent class cluster analysis to understand heterogeneity in prostate cancer treatment utilities, BMC Med Inform Decis Mak 9:47, 2009.
22. Rajan P, Elliott DJ, Robson CN, Leung HY, Alternative splicing and biological heterogeneity in prostate cancer, Nat Rev Urol 6:454-460, 2009.
23. Brower V, Watchful waiting beats androgen deprivation therapy in early prostate cancer, J Natl Cancer Inst 100:1494-1496, 2008.
24. Ganti AK, Huang CH, Klein MA, Keefe S, Kelley MJ, Lung cancer management in 2010, Oncology (Williston Park) 25:64-73, 2010.